<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Wynne N</submitter><funding>NEI NIH HHS</funding><funding>National Eye Institute</funding><funding>Research to Prevent Blindness</funding><funding>Foundation Fighting Blindness</funding><funding>FDA HHS</funding><pagination>100920</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8639282</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>83</volume><pubmed_abstract>Adaptive optics scanning light ophthalmoscopy (AOSLO) allows visualization of the living human retina with exquisite single-cell resolution. This technology has improved our understanding of normal retinal structure and revealed pathophysiological details of a number of retinal diseases. Despite the remarkable capabilities of AOSLO, it has not seen the widespread commercial adoption and mainstream clinical success of other modalities developed in a similar time frame. Nevertheless, continued advancements in AOSLO hardware and software have expanded use to a broader range of patients. Current devices enable imaging of a number of different retinal cell types, with recent improvements in stimulus and detection schemes enabling monitoring of retinal function, microscopic structural changes, a</pubmed_abstract><journal>Progress in retinal and eye research</journal><pubmed_title>Promises and pitfalls of evaluating photoreceptor-based retinal disease with adaptive optics scanning light ophthalmoscopy (AOSLO).</pubmed_title><pmcid>PMC8639282</pmcid><funding_grant_id>P30 EY002162</funding_grant_id><funding_grant_id>U01 EY025477</funding_grant_id><funding_grant_id>R01 EY021237</funding_grant_id><funding_grant_id>U24 EY029891</funding_grant_id><funding_grant_id>R01 EY023591</funding_grant_id><funding_grant_id>R01 FD004100</funding_grant_id><funding_grant_id>R01 EY017607</funding_grant_id><pubmed_authors>Duncan JL</pubmed_authors><pubmed_authors>Carroll J</pubmed_authors><pubmed_authors>Wynne N</pubmed_authors></additional><is_claimable>false</is_claimable><name>Promises and pitfalls of evaluating photoreceptor-based retinal disease with adaptive optics scanning light ophthalmoscopy (AOSLO).</name><description>Adaptive optics scanning light ophthalmoscopy (AOSLO) allows visualization of the living human retina with exquisite single-cell resolution. This technology has improved our understanding of normal retinal structure and revealed pathophysiological details of a number of retinal diseases. Despite the remarkable capabilities of AOSLO, it has not seen the widespread commercial adoption and mainstream clinical success of other modalities developed in a similar time frame. Nevertheless, continued advancements in AOSLO hardware and software have expanded use to a broader range of patients. Current devices enable imaging of a number of different retinal cell types, with recent improvements in stimulus and detection schemes enabling monitoring of retinal function, microscopic structural changes, a</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Jul</publication><modification>2025-04-19T10:49:47.564Z</modification><creation>2025-04-19T10:49:47.564Z</creation></dates><accession>S-EPMC8639282</accession><cross_references><pubmed>33161127</pubmed><doi>10.1016/j.preteyeres.2020.100920</doi></cross_references></HashMap>